ABOUT U-73122

Compound 60 has an exceedingly higher affinity to MDM2 (Ki < 1 nM), strong cellular action, and an excellent oral pharmacokinetic profile. Compound sixty is capable of attaining comprehensive and prolonged-lasting tumor regression in vivo and is now in stage I clinical trials for cancer treatment method.Be sure to see Inhibitor Managing Guidance Fo